Stay updated on Datopotamab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Datopotamab in Lung Cancer Clinical Trial page.

Latest updates to the Datopotamab in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2 and last update timestamps were added (2025-11-26 and 2025-11-24), along with the estimated primary completion date of 2028-04. These are metadata changes and do not modify the study design, eligibility criteria, locations, interventions, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedRevision entry updated: v3.2.0 was removed and v3.3.1 was added.SummaryDifference0.1%

- Check29 days agoChange DetectedThe top government funding and operating status notice, including the NIH Clinical Center update and related links, has been removed from the page.SummaryDifference0.4%

- Check43 days agoChange DetectedThe new screenshot shows only minor visual adjustments and an updated last-update timestamp; there are no changes to the study design, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check79 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Datopotamab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Datopotamab in Lung Cancer Clinical Trial page.